Invesco
CLBT icon

Invesco’s Cellebrite CLBT Stock Holding History

Invesco’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-858,034
Closed -$11.8M – 3841
2026
Q1 		$11.8M Sell
858,034
-4,745,203
-85% -$71.5M ﹤0.01% 1742
2025
Q4 		$101M Buy
5,603,237
+43,041
+0.8% +$773K 0.01% 831
2025
Q3 		$103M Buy
5,560,196
+2,054,644
+59% +$32.3M 0.02% 839
2025
Q2 		$56.1M Buy
3,505,552
+209,473
+6% +$3.73M 0.01% 1019
2025
Q1 		$64M Buy
3,296,079
+1,811,757
+122% +$38.1M 0.01% 940
2024
Q4 		$32.7M Buy
+1,484,322
New +$28.6M 0.01% 1244

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Invesco's CLBT Position: Q2 2026 in Review

Invesco sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 858,034 shares — an estimated $11.8M sold.

Invesco first reported a position in CLBT in Q4 2024 and held it in 6 quarters. The position peaked at $103M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Invesco reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Invesco sold 858,034 Cellebrite shares in Q2 2026, an estimated $11.8M.
  • Invesco first reported a position in Cellebrite in Q4 2024 and held it in 6 quarters.
  • Invesco's Cellebrite position peaked at $103M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.